Andra AP-fonden’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.2K | Buy |
+300
| New | +$26.2K | ﹤0.01% | 465 |
|
|
2024
Q4 | – | Sell |
-115,500
| Closed | -$7.74M | – | 414 |
|
|
2024
Q3 | $7.74M | Buy |
+115,500
| New | +$7.74M | 0.11% | 260 |
|
|
2023
Q3 | – | Sell |
-42,100
| Closed | -$5.41M | – | 356 |
|
|
2023
Q2 | $5.41M | Buy |
42,100
+6,300
| +18% | +$810K | 0.14% | 355 |
|
|
2023
Q1 | $4.16M | Sell |
35,800
-3,400
| -9% | -$395K | 0.11% | 411 |
|
|
2022
Q4 | $4.44M | Sell |
39,200
-1,600
| -4% | -$181K | 0.13% | 345 |
|
|
2022
Q3 | $3.29M | Sell |
40,800
-4,900
| -11% | -$395K | 0.11% | 391 |
|
|
2022
Q2 | $3.41M | Buy |
+45,700
| New | +$3.41M | 0.1% | 432 |
|
|
2021
Q4 | $1.34M | Buy |
+10,000
| New | +$1.34M | 0.03% | 524 |
|
|
2021
Q1 | – | Sell |
-32,400
| Closed | -$3M | – | 588 |
|
|
2020
Q4 | $3M | Sell |
32,400
-23,200
| -42% | -$2.14M | 0.07% | 526 |
|
|
2020
Q3 | $5.73M | Sell |
55,600
-25,600
| -32% | -$2.64M | 0.16% | 307 |
|
|
2020
Q2 | $8.23M | Sell |
81,200
-13,200
| -14% | -$1.34M | 0.24% | 62 |
|
|
2020
Q1 | $6.36M | Buy |
94,400
+38,800
| +70% | +$2.61M | 0.23% | 57 |
|
|
2019
Q4 | $3.04M | Buy |
55,600
+5,600
| +11% | +$306K | 0.09% | 554 |
|
|
2019
Q3 | $1.87M | Sell |
50,000
-22,000
| -31% | -$821K | 0.06% | 609 |
|
|
2019
Q2 | $2.7M | Sell |
72,000
-12,400
| -15% | -$464K | 0.08% | 583 |
|
|
2019
Q1 | $2.51M | Buy |
+84,400
| New | +$2.51M | 0.07% | 575 |
|